Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Piacenza
Clinical trial register · Italy

Clinical Trials in Piacenza, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Azienda Unita Sanitaria Locale di Piacenza3 Fondazione Italiana Linfomi - ETS2 IRCCS Azienda Ospedaliero-Universitaria di Bologna2 University Hospital of Ferrara2 Gruppo Italiano Malattie EMatologiche dell'Adulto2
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Piacenza

29 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Liaquat University of Medical & Health Sciences
Not applicable
255
Piacenza, Guidonia Montecelio, Rome, Urbino
2026-09-07
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
150
Bologna, Meldola, Mantua, Carpi, Modena, Sassuolo, Piacenza, Parma
2026-07-30
Recruiting
Telemedicine-guided Uptitration of Therapy in Chronic Heart Failure
NCT07518030Heart Failure With Reduced Ejection Fraction (HFrEF)
Azienda Unita Sanitaria Locale di Piacenza
Not applicable
80
Piacenza
2026-03-20
Not yet open
Effects of Music on Procedural Pain in Distal Radius Fracture Reduction
NCT07344883Pain, Blood Pressure, Heart Rate, Music Therapy
Azienda Unita Sanitaria Locale di Piacenza
Not applicable
192
Piacenza
2026-02
Recruiting
Takeda
Phase 3
347
Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Torino
2025-07-15
Recruiting
Biogen
Phase 3
454
Bari, Fontevivo, Modena, Piacenza, Trieste, Genoa, Brescia, Ranica
2025-05-08
Recruiting
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
NCT07174102Reumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), Idiopathic Pulmonary Fibrosis (IPF), Connective Tissue Disease (CTD)
Azienda Unita Sanitaria Locale di Piacenza
Observational
500
Ferrara, Modena, Piacenza, Reggio Emilia
2025-01-08
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Bologna, Cremona, Florence, Milan, Modena, Padova, Piacenza, Roma
2024-12-13
By invitation
Mario Stirpe
Observational
96
Acquaviva delle Fonti, Altamura, Cuneo, Florence, Piacenza, Sassari, Venezia, Vercelli
2024-11-28
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Naples, Ferrara, Piacenza, Florence, Livorno, Bergamo, Milan, Pesaro
2024-07-16
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
31
Arezzo, Bolzano, Catania, Pavia, Piacenza
2024-06-30
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
56
Avellino, Alessandria, Biella, Milan, Novara, Pavia, Piacenza, Torino
2024-05-07
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Caserta, Florence, Genova, Grosseto, Monza, Milan, Piacenza, Gubbio
2024-04-11
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
24
Piacenza
2023-12-13
Recruiting
Biologic Characterization of Patients With ITP
NCT05694325Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
200
Bologna, Piacenza, Roma, Torino, Trieste
2023-11-27
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Catania, Forlì, Genoa, Lecco, Lucca, Milan, Parma, Piacenza
2023-07-17
Active, closed
University Hospital of Ferrara
Not applicable
1,823
Bologna, Ferrara, Bolzano, Catanzaro, Cosenza, Baggiovara, Piacenza, Parma
2023-05-08
Recruiting
Pfizer
Phase 3
1,060
Meldola (Fc), Piacenza, Ravenna, San Giovanni Rotondo, Aviano, Monza, Turin, Palermo
2022-11-10
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,055
Cosenza, Reggio Calabria, Naples, Bologna, Ferrara, Parma, Piacenza, Ravenna
2022-05-06
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Bologna, Genova, Pavia, Piacenza
2022-04-05
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Not applicable
100
Meldola, Bologna, Ferrara, Parma, Piacenza, Ravenna, Reggio Emilia, Rimini
2022-03-01
Active, closed
MedSIR
Phase 2
393
Bologna, Milan, Monza, Parma, Piacenza, Roma
2021-08-05
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
430
Brescia, Piacenza, Rionero in Vulture, Alessandria, Ancona, Ascoli Piceno, Aviano, Barletta
2021-03-23
Active, closed
University Hospital of Ferrara
Not applicable
512
Bologna, Ferrara, Piacenza, Lagosanto
2020-03-27
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
206
Ponderano, Lecco, Catania, Grosseto, Province of Macerata, Monza, Modena, Piacenza
2020-03-02
Recruiting
Population Health Research Institute
Phase 4
2,270
Milan, Alessandria, Palermo, Piacenza
2019-06-14
Active, closed
MedSIR
Phase 2
377
Bologna, Brindisi, Cremona, Mantua, Milan, Monza, Piacenza
2017-06-26
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/piacenza

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Piacenza.

How many clinical trials are recruiting in Piacenza?

16 of the 29 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 9 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Piacenza), 29 studies
PhaseStudiesRecruitingShare
Not applicable10634.5%
Observational6420.7%
Phase 36420.7%
Phase 24013.8%
Phase 2/3216.9%
Phase 4113.4%

Most active sponsors

Lead sponsors with the most studies (Piacenza)
Lead sponsorStudiesRecruiting
Azienda Unita Sanitaria Locale di Piacenza32
Fondazione Italiana Linfomi - ETS21
Gruppo Italiano Malattie EMatologiche dell'Adulto22
IRCCS Azienda Ospedaliero-Universitaria di Bologna22
MedSIR20
University Hospital of Ferrara20
Arcus Biosciences, Inc.10
Azienda Ospedaliero-Universitaria di Parma11
Azienda USL Reggio Emilia - IRCCS11
Biogen11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.